Maximum quantity allowed is 999
请选择数量
CAS RN: 59729-32-7 | 產品號碼: C2370
Citalopram Hydrobromide
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | C2370 |
| 純度/分析方法 | >98.0%(T)(HPLC) |
| 分子式 / 分子量 | C__2__0H__2__1FN__2O·HBr = 405.31 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Room Temperature (Recommended in a cool and dark place, <15°C) |
| 包裝和容器 | 1G-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 59729-32-7 |
| 相關CAS RN | 59729-33-8 |
| Reaxys-RN | 5368282 |
| PubChem Substance ID | 125307911 |
| Merck Index(14) | 2318 |
| MDL編號 | MFCD02101306 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 98.0 % |
| NMR | confirm to structure |
性質
| 熔點 | 183 °C(dec.) |
GHS
相關法規
| RTECS # | NP6406750 |
運輸資料
| HS編碼* | 2932.99-000 |
Application
Citalopram Hydrobromide: A Selective Serotonin Reuptake Inhibitor (SSRI)
Citalopram hydrobromide is a selective serotonin reuptake inhibitor (SSRI). It is a racemic bicyclic phthalane derivative consisting of a 1:1 mixture of the R(-)- and S(+)[E0958] -enantiomers. The mechanism of action of citalopram HBr as an antidepressant is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT) [S0370]. In vitro and in vivo studies suggest that citalopram a highly SSRI with minimal effects on norepinephrine (NA) [A0906] and dopamine (DA) [A0305] neural reuptake. In additon, citalopram has no antagonistic activity towards DA, NA, 5-HT, histamine [H0146, H0147], GABA [A0282], acetylcholine [A0084, chloride], and morphine receptors. Although, the inhibition primarily due to the active S(+)-enantiomer, it is reported that the R(-)-enantiomer counteracts the activity of the S(+)[E0958] -enantiomer. (The product is for research purpose only.)
References
- Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity
- Citalopram (a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness)
- Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram
- Escitalopram versus citalopram: the surprising role of the R-enantiomer
- Determination of citalopram and escitalopram together with their active main metabolites desmethyl(es-)citalopram in human serum by column-switching high performance liquid chromatography (HPLC) and spectrophotometric detection
- Analytical procedures for the determination of the selective serotonin reuptake inhibitor antidepressant citalopram and its metabolites (a review)
考研文獻
文章/手冊
TCIMail
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。